C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, USA, was a developer, manufacturer, and marketer of medical technologies in the vascular medicine, urology, oncology, and surgical specialty fields. C. R. Bard marketed its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.

An S&P 500 company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the Foley catheter in 1934.

In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company (BD). The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.